Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia

被引：1
|
作者：
Neupane, Niraj [1 ]
Low, Soon K. [2 ]
Kharel, Himal [1 ]
Bhattarai, Sanket [3 ]
Thapa, Sangharsha [4 ]
Mahmoud, Amir [1 ]
Pokhrel, Nishant B. [5 ]
Din, Mohammad Ammad Ud [6 ]
Kouides, Peter [7 ]
机构：
[1] Rochester Gen Hosp, Dept Internal Med, Rochester, NY 14621 USA
[2] Med Coll Wisconsin, Dept Hematol & Oncol, Milwaukee, WI USA
[3] Mayo Clin, Rochester, MN USA
[4] New York Med Coll, Westchester Med Ctr, Dept med, Westchester, NY USA
[5] Norwalk Hosp, Dept Internal Med, Norwalk, CT USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol & Oncol, Tampa, FL USA
[7] Rochester Gen Hosp, Lipson Canc Inst, Dept Hematol, Rochester, NY USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2024年 / 99卷 / 01期
关键词：
PROGNOSIS; SUBTYPES;
D O I：
10.1002/ajh.27148
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E26 / E28
页数：3
相关论文
共 50 条
  • [41] JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort
    McGaffin, Gillian
    Harper, Kirsteen
    Stirling, David
    McLintock, Lorna
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (02) : 276 - 278
  • [42] Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients
    Limsuwanachot, N.
    Rerkamnuaychoke, B.
    Chuncharunee, S.
    Pauwilai, T.
    Singdong, R.
    Rujirachaivej, P.
    Chareonsirisuthigul, T.
    Siriboonpiputtana, T.
    HEMATOLOGY, 2017, 22 (10) : 599 - 606
  • [43] Assessment of JAK2 V617F mutation in Tunisian patients with essential thrombocythemia
    Belhiba, M.
    Bellaaj, H.
    Keskes, L.
    Frikha, R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1016 - 1016
  • [44] Calr mutations are associated with lower platelet and endothelial activation than the JAK2 mutation in essential thrombocythemia
    Arellano-Rodrigo, E.
    Alvarez-Larran, A.
    Reverter, J-C
    Colomer, D.
    Bellosillo, B.
    Cervantes, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 418 - 418
  • [45] MOLECULAR STUDY OF CALR GENE: MYELOPROLIFERATIVE NEOPLASMS (MPN) WITH NEGATIVE PHILADELPHIA AND JAK2/V617F
    Culurgioni, F.
    Musiu, C.
    Uda, S.
    Benziane, A.
    Pettinau, M.
    Usala, E.
    Cabras, M. G.
    HAEMATOLOGICA, 2017, 102 : 167 - 168
  • [46] COEXISTENCE OF MUTATIONS IN JAK2V617F AND CALR IN PATIENTS WITH ESSENTIAL TROMBOCITEMIA IN A CENTER
    Saez Perdomo, M.
    Gonzalez Perez, E.
    Sanchez Sosa, S.
    Florido Ortega, Y.
    Bilbao Sieyro, C.
    Stuckey, R.
    De la Iglesia Inigo, S.
    Saez Salinas, A.
    Santana Santana, G.
    Segura Diaz, A.
    Molero Labarta, T.
    Gomez Casares, M. T.
    HAEMATOLOGICA, 2018, 103 : 233 - 234
  • [47] IMPACT OF VARIANT ALLELE FREQUENCY (VAF) OF JAK2V617F AND CALR MUTATIONS ON THROMBO-HEMORRHAGIC RISK IN ESSENTIAL THROMBOCYTHEMIA
    Bertozzi, I.
    Lombardi, A. M.
    Bogoni, G.
    Vezzaro, T.
    Fabris, F.
    Randi, M. L.
    HAEMATOLOGICA, 2019, 104 : 72 - 73
  • [48] INFLUENCE OF THE JAK2 V617F HOMOZYGOUS OR HETEROZYGOUS MUTATION AND OF INHERITED THROMBOPHILIA ON THE THROMBOTIC RISK AMONG PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    De Stefano, V.
    Za, T.
    Fiorini, A.
    Rossi, E.
    Ciminello, A.
    Chiusolo, P.
    Sica, S.
    Leone, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 299 - 299
  • [49] Development of a PCR Assay for Detection of JAK2 Exon 14 (V617F), JAK2 Exon 12 and CALR Exon 9 Mutations in Myeloproliferative Disorders
    Maxwell, D. C.
    Grenier, S.
    Nwachukwu, B.
    Jensen, M.
    Morrison, W.
    Stockley, T. L.
    Karnel-Reid, S.
    Wei, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 959 - 959
  • [50] Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN)
    Zulkeflee, Razan Hayati
    Zulkafli, Zefarina
    Johan, Muhammad Farid
    Husin, Azlan
    Islam, Md Asiful
    Hassan, Rosline
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (14)
12345